Infleqtion, Inc. engages in the development and commercialization of quantum technology products in the United States, Europe, and Asia. It delivers neutral atom solutions for quantum computing, networking, sensing, and security. The company offers quantum sensing, quantum computing and software; quantum clocks and quantum RF sensors; and quantum inertial and gravimetric sensors for GPS-denied environments. It also offers quantum computing; contextual machine learning; quantum software; tiqker atomic clock; quantum RF receiver; inertial sensing; and quantum cores products, as well as quantum optical clocks, RF receivers, and inertial sensors. In addition, the company offers solutions for national security and resilience, space and frontier, energy and resource exploration, ai and ml, life sciences and drug discovery, materials science, and finance. It serves organizations in national security, critical national infrastructure, scientific discovery, advanced computing, space, defense, energy, finance, and telecommunications sectors. It has a collaboration with Japan Science and Technology Agency for developing quantum computers. The company was formerly known as ColdQuanta, Inc. and changed its name to Infleqtion, Inc. in January 2026. The company was founded in 2007 and is headquartered in Louisville, Colorado.…
memQ and Infleqtion Sign MoU to Advance Networked Quantum Computing
Infleqtion (NYSE: INFQ) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Software - Infrastructure industry, part of the Technology sector, and reports about 203 employees.
The shares were at 6.320 USD on 20 November 2026. Its 52-week range is 6.255 USD to 21.28 USD: the price is 70.3% below the high and 1.0% above the low.
Its market capitalisation is 1.43B USD.
Infleqtion reports return on equity of 29.4%, an operating margin of -220.8% and revenue up 25.1% year over year.
It holds more cash than debt, a net cash position of 461.80M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 7 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 18.14 USD is 187.1% above the current price. The next earnings report is expected on 31 March 2027.